Skip to main content
. 2016 Dec 8;116(2):186–194. doi: 10.1038/bjc.2016.401

Figure 2.

Figure 2

Disease-specific survival calculated by the Kaplan—Meier method in patients who underwent gastrectomy for resectable gastric cancer (GC). (A) disease-specific survival in patients with or without CD44s expression at the invasive tumour front (ITF); (B) disease-specific survival in patients with or without CD44v6 expression at the ITF; (C) disease-specific survival in patients with or without CD44v9 expression at the ITF; (D) disease-specific survival in patients with the expression of more than one CD44 isoforms at the ITF; all-negative: patients who stained negative for all the CD44 isoforms at the ITF; single-positive: patients showing positive staining for one CD44 isoform at the ITF; double-positive: patients showing positive staining for two CD44 isoforms at the ITF; all-positive: patients showing positive staining for all the CD44 isoforms at the ITF.